drugset / Trial / NCT01726920
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether a fixed-dose combination of naratriptan 2,5 mg + naproxen 500 mg is effective and safe compared each monotherapy for the acute treatment of migraine.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | — |
| Comparator | naratriptan | Small molecule | 2.5 mg | — |